Welcome to the Australian and New Zealand Journal of Psychiatry, a premier publication dedicated to advancing the field of psychiatric research and mental health practices. Published by SAGE Publications Ltd, this esteemed journal has been a pivotal source of knowledge since its inception in 1967, contributing to the global discourse on psychiatric issues and innovations. With an impressive impact factor positioning it in the Q1 category for both Medicine (miscellaneous) and Psychiatry and Mental Health, it ranks among the top journals with a Scopus rank of #79 out of 567, placing it in the 86th percentile. This journal is committed to fostering interdisciplinary research and clinical practices, providing a platform for high-quality original articles, reviews, and case studies. While it does not currently offer open access options, the insights garnered within its pages are invaluable for researchers, practitioners, and students striving to make impactful contributions to mental health developments. Join our community and explore the dynamic narratives shaping psychiatric science and practice.

Annals of General Psychiatry is a leading open-access journal published by BMC, dedicated to advancing the field of psychiatry and mental health. Since its inception in 2005, the journal has provided a robust platform for researchers to disseminate peer-reviewed clinical and experimental studies, case reports, and reviews that address the broad spectrum of psychiatric disorders. With an impressive Q1 ranking in Psychiatry and Mental Health for 2023, and a notable Scopus rank of #128 out of 567 in its category, the journal plays a pivotal role in disseminating high-quality, impactful research within the global scientific community. The open access model guarantees wide visibility and accessibility of research findings, ensuring that professionals, students, and policymakers can utilize the latest advancements in the psychiatric field. The journal's presence from 2002 to 2024 further demonstrates its commitment to contributing valuable insights that are relevant to contemporary challenges in mental health.

Rivista di Psichiatria, published by PENSIERO SCIENTIFICO EDITORE, stands as a significant contributor to the field of Psychiatry and Mental Health since its inception in 1975. With an ISSN of 0035-6484 and an E-ISSN of 2038-2502, this esteemed journal offers a platform for rigorous academic discourse and cutting-edge research, helping to shape contemporary psychiatric practices and theories. Currently holding a Q2 designation in Psychiatry and Mental Health based on the 2023 category quartiles, and ranking #197 out of 567 in Scopus, it reflects a commendable 65th percentile among its peers. The journal welcomes contributions that encompass a broad range of topics related to mental health, encouraging contributions from a multidisciplinary approach, which aids in its goal of advancing the understanding and application of psychiatric science. While it is a traditional journal without Open Access options, access to its valuable content can support researchers, clinicians, and students in their pursuit of knowledge and innovation within the field. Situated in Rome, Italy, at VIA SAN GIOVANNI VALDARNO 8, ROME 00138, the journal continues to enhance its rich legacy, promoting the exchange of ideas and fostering collaboration amongst practitioners and scholars alike.

HARVARD REVIEW OF PSYCHIATRY is a prestigious academic journal focused on the field of psychiatry and mental health, published by Lippincott Williams & Wilkins. Established in 1993, this journal has become a critical resource for researchers, clinicians, and students alike, providing cutting-edge insights and scholarly articles that address contemporary issues in mental health. With an impressive impact factor reflected in its Q1 ranking in Psychiatry and Mental Health, the journal ranks #90 out of 567 in its category in Scopus, placing it in the top 16% of publications in this field. The journal is dedicated to disseminating high-quality research and fostering dialogue among professionals, thus contributing significantly to the advancement of psychiatric sciences. Researchers can access the journal through traditional subscriptions, ensuring that vital knowledge and innovative practices are shared among a global audience.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.

PSYCHIATRY-INTERPERSONAL AND BIOLOGICAL PROCESSES, published by Routledge Journals, Taylor & Francis Ltd, is a pivotal journal in the field of psychiatry, focusing on the intricate interplay between interpersonal relationships and biological factors in mental health. Established in 1938, the journal has cultivated a rich legacy of scholarship, with a projected convergence of research extending to 2024. With an impact that resonates through its Q2 ranking in Medicine (miscellaneous) and Q3 in Psychiatry and Mental Health as of 2023, it ranks 325th among 567 in its category on Scopus, highlighting its relevance and reach within the academic landscape. While it is not an open-access journal, it serves a vital role in disseminating cutting-edge research, encouraging multidisciplinary dialogue among researchers, clinicians, and students alike. The journal’s dedication to exploring complex psychiatric issues makes it an indispensable resource for advancing knowledge and enhancing clinical practice in mental health.

Translational Psychiatry, an esteemed journal published by SpringerNature, is at the forefront of research in the fields of biological psychiatry, neuroscience, and mental health. With an impressive Q1 category ranking in Biological Psychiatry, Cellular and Molecular Neuroscience, and Psychiatry and Mental Health, the journal fosters high-quality scholarly work that informs clinical practices and guides future research directions. Since its inception in 2011, Translational Psychiatry has embraced the Open Access model, ensuring that groundbreaking findings are easily accessible to all, promoting collaboration and innovation within the global scientific community. With a solid ranking in Scopus—particularly at #33 out of 567 in Psychiatry and Mental Health and #6 out of 51 in Biological Psychiatry—this journal plays a critical role in advancing our understanding of mental health disorders, bridging the gap between bench science and clinical application. As it continues evolving through its converged years from 2011 to 2024, Translational Psychiatry remains an essential resource for researchers, healthcare professionals, and students dedicated to improving mental health outcomes.

NORDIC JOURNAL OF PSYCHIATRY is a pivotal publication in the field of psychiatry and mental health, dedicated to advancing knowledge and fostering dialogue among researchers, clinicians, and students. Published by Taylor & Francis Ltd, this esteemed journal, with an ISSN of 0803-9488 and E-ISSN 1502-4725, serves as a platform for innovative research and critical reviews that address crucial mental health issues affecting Nordic populations and beyond. Its impact is underscored by a notable Q2 ranking in the Psychiatry and Mental Health category for 2023, along with a respectable position within the Scopus ranking at #268 out of 567. The journal has been a reliable source of scientific inquiry since its inception in 1947, and it aims to facilitate significant advancements in the understanding and treatment of psychiatric disorders. By providing access to high-quality research without open access options, NORDIC JOURNAL OF PSYCHIATRY remains a must-read for those dedicated to progressing mental health science in a global context.

European Archives of Psychiatry and Clinical Neuroscience is a prominent peer-reviewed journal published by Springer Heidelberg, focusing on the interdisciplinary aspects of psychiatry and clinical neuroscience. With an ISSN of 0940-1334 and an E-ISSN of 1433-8491, this journal provides a rigorous platform for innovative research spanning biological psychiatry, pharmacology, and various aspects of mental health. The journal boasts a distinguished impact factor that places it in the Q2 category for Biological Psychiatry and Q1 in both Medicine (miscellaneous) and Psychiatry and Mental Health as of 2023, reflecting its significant contribution to the field. Additionally, its Scopus rankings highlight its esteemed position among the top journals, particularly in Medicine and Neuroscience disciplines. Readers can access a wealth of valuable research articles, case studies, and reviews, crucial for advancing understanding and treatment within these vital fields. Initially converged in 1990, the journal continues to evolve and support scholarly dialogue until 2024 and beyond, making it an essential resource for researchers, clinicians, and students alike.

INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE is a distinguished publication dedicated to advancing the understanding of psychiatric practice and mental health issues within a medical framework. Published by SAGE PUBLICATIONS INC, this journal has been a trusted source in the field since its inception, with its archives dating back to 1973. It offers a comprehensive exploration of psychiatric research, clinical studies, and theoretical advancements that seek to bridge the gap between psychiatry and general medicine. With an impact factor reflective of its quality and relevance, categorized in the Q3 quartile in Psychiatry and Mental Health, this journal stands as a vital resource for researchers, clinicians, and students alike. Although operating on a traditional subscription model, the extensive knowledge shared within its pages contributes significantly to ongoing discussions in psychiatric and mental health education and practice. As the field continually evolves, the INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE remains committed to fostering innovative and impactful scholarship that resonates with professionals navigating the complexities of mental health in clinical contexts.